Katherine Anne Askenasy is a Houston, Texas based nurse practitioner. Active license number of Katherine Anne Askenasy is 696172 in Texas. Her current practice location is 6701 Fannin St, Houston. Patients can reach her at 832-822-4890. Katherine Anne Askenasy is NP and her NPI number (Unique professional ID assigned by NPPES) is 1760662688. Katherine Anne Askenasy has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Katherine Anne Askenasy speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1760662688
NPI Enumeration Date:
08 Nov, 2007
NPI Last Update On:
27 Jan, 2009
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Katherine Anne Askenasy are as mentioned below.
License Number
Specialization
State
Status
696172
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Katherine Anne Askenasy 2 Greenway Plz, Suite 900 Houston, Texas
Zip:
77046-0297
Phone Number:
713-798-1750
Fax Number:
713-798-1144
Patients can reach Katherine Anne Askenasy at 6701 Fannin St, Houston, Texas or can call to book an appointment on 832-822-4890.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.